Farewell to a visionary: Dr. Tian-Lu Cheng (1967–2024)

On 4th December, the biotech and academic worlds mourned the sudden passing of Dr. Tian-Lu Cheng, Vice President of Kaohsiung Medical University (K.M.U) and CEO of the K.M.U Research Center for Drug Development and Value Creation (DVCR). Known as the Tech Transfer Titan of Southern Taiwan, Dr. Cheng dedicated over 30 years to antibody research, securing over 500 tech transfers and generating royalties exceeding USD 6 million.

Dr. Cheng’s legacy extends beyond numbers—his mentorship inspired startups like CytoArm and PrecisemAb Biotech, making waves in Taiwan's biomedical ecosystem. As a pioneer, educator, and innovator, he believed in the power of science to transform lives. Outside the lab, his vibrant personality shone through hobbies like comics, sports, fishing, mahjong, chess, and wine tasting.

His groundbreaking achievements and warm spirit will continue to inspire future generations.

Learn more about Dr. Cheng's incredible journey and contributions (Written in Chinese):

30 years to antibody research,  the Tech Transfer Titan of Southern Taiwan generated royalties over USD 6 million (2021-02-02) https://reurl.cc/V0DL0N
 
From bench to bedside, Dr. Tian-Lu Cheng guides us through the journey of innovation (2024-01-15)
https://reurl.cc/Q5LX52
 
The disciple of theTech Transfer Titan of Southern Taiwan, scientist Chuang's BsAb Armed-T Cells enter clinical practice (2024-03-26)
https://reurl.cc/qn5Ln3

Winner of the 2nd Globalbio's CEO Award announced!
Taiwan’s young biomedical leader Chuang, CEO at CytoArm, won the first place (2023-10-26)
https://reurl.cc/mRoDRj
 
Universal Antibody Lock, Authorized from Professor Cheng of the KMU, invites cooperation from the United States, Japan and South Korea (2024-06-11)
https://reurl.cc/ZZAWZp
 
A new generation of Taiwanese biomedical CEOs qualify! Lu Yunqi, a master's degree student in biotechnology, won the third place (2024-10-25)
https://reurl.cc/04p1Ko